glycyrrhizic acid has been researched along with Pulmonary Arterial Remodeling in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Dou, Y; Feng, D; Li, H; Liu, C; Shen, H; Sun, L; Sun, Q; Tian, X; Wang, Z; Zhou, F | 1 |
| Chang, HJ; Kang, WJ; Kim, DH; Lee, SE; Lee, YJ; Shin, JS; Yang, PS | 1 |
2 other study(ies) available for glycyrrhizic acid and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
HMGB1 promotes neurovascular remodeling via Rage in the late phase of subarachnoid hemorrhage.
Topics: Animals; Benzamides; Brain; Brain Injuries; Cerebral Cortex; Disease Models, Animal; Doublecortin Protein; Glycyrrhizic Acid; HMGB1 Protein; Male; Neurons; Pyruvates; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Recombinant Proteins; Signal Transduction; Subarachnoid Hemorrhage; Vascular Remodeling | 2017 |
Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Topics: Animals; Antihypertensive Agents; Arterial Pressure; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin-1; Glycyrrhizic Acid; HMGB1 Protein; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Muscle, Smooth, Vascular; Pneumonia; Pulmonary Artery; Rats, Sprague-Dawley; Time Factors; Vascular Remodeling; Ventricular Dysfunction, Right; Ventricular Function, Right | 2014 |